CD274 and melanoma: Thus, we analyzed whether patients with melanoma BM receiving checkpoint inhibitors as a monotherapy (n = 2) or in combination with chemotherapy (n = 6), radiotherapy (n = 6) or both (n = 13) at any time of disease might gain a clinical benefit from high PD-L1 expression in their brain metastases.